Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary

Background: COVID-19 may play a role in various immune-related dermatologic conditions. The relationship between COVID-19 and alopecia areata remains unclear. Objective: To review the existing literature for clinical studies and reports investigating the association between new-onset alopecia areata...

Full description

Bibliographic Details
Main Authors: Rachel E. Christensen, BS, Mohammad Jafferany, MD
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:JAAD International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666328722000177
_version_ 1811257422887518208
author Rachel E. Christensen, BS
Mohammad Jafferany, MD
author_facet Rachel E. Christensen, BS
Mohammad Jafferany, MD
author_sort Rachel E. Christensen, BS
collection DOAJ
description Background: COVID-19 may play a role in various immune-related dermatologic conditions. The relationship between COVID-19 and alopecia areata remains unclear. Objective: To review the existing literature for clinical studies and reports investigating the association between new-onset alopecia areata or the exacerbation of preexisting alopecia areata following infection with SARS-CoV-2. Methods: A systematic review of the literature was performed using PubMed, Embase, and MEDLINE databases from inception to October 2021. Included articles assessed alopecia areata following infection with SARS-CoV-2. Results: Of 402 total articles, 9 were identified as meeting the inclusion criteria. Six articles described case reports of 7 patients with new-onset alopecia areata following confirmed infection with SARS-CoV-2, and 3 articles reported on alopecia areata recurrence or exacerbation following SARS-CoV-2 infection in patients with preexisting disease. Studies investigating the exacerbation or recurrence of alopecia areata following infection reported mixed findings. Limitations: A majority of the included studies were case reports. The heterogeneity of articles precluded data synthesis. Conclusion: Alopecia areata may be a dermatologic manifestation of COVID-19, with cases most often appearing 1 to 2 months following infection. Additional research is necessary to better elucidate the relationship and draw conclusions.
first_indexed 2024-04-12T17:56:15Z
format Article
id doaj.art-1256246bd48b4d7da2d7402d32f712bb
institution Directory Open Access Journal
issn 2666-3287
language English
last_indexed 2024-04-12T17:56:15Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series JAAD International
spelling doaj.art-1256246bd48b4d7da2d7402d32f712bb2022-12-22T03:22:19ZengElsevierJAAD International2666-32872022-06-0175761Association between alopecia areata and COVID-19: A systematic reviewCapsule SummaryRachel E. Christensen, BS0Mohammad Jafferany, MD1Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey; Correspondence to: Rachel E. Christensen, BS, Rutgers Robert Wood Johnson Medical School, 125 Paterson Street, New Brunswick, NJ 08901.Department of Psychiatry and Behavioral Sciences, Central Michigan University College of Medicine, Mount Pleasant, MichiganBackground: COVID-19 may play a role in various immune-related dermatologic conditions. The relationship between COVID-19 and alopecia areata remains unclear. Objective: To review the existing literature for clinical studies and reports investigating the association between new-onset alopecia areata or the exacerbation of preexisting alopecia areata following infection with SARS-CoV-2. Methods: A systematic review of the literature was performed using PubMed, Embase, and MEDLINE databases from inception to October 2021. Included articles assessed alopecia areata following infection with SARS-CoV-2. Results: Of 402 total articles, 9 were identified as meeting the inclusion criteria. Six articles described case reports of 7 patients with new-onset alopecia areata following confirmed infection with SARS-CoV-2, and 3 articles reported on alopecia areata recurrence or exacerbation following SARS-CoV-2 infection in patients with preexisting disease. Studies investigating the exacerbation or recurrence of alopecia areata following infection reported mixed findings. Limitations: A majority of the included studies were case reports. The heterogeneity of articles precluded data synthesis. Conclusion: Alopecia areata may be a dermatologic manifestation of COVID-19, with cases most often appearing 1 to 2 months following infection. Additional research is necessary to better elucidate the relationship and draw conclusions.http://www.sciencedirect.com/science/article/pii/S2666328722000177AAalopecia areataCOVID-19inflammationSARS-CoV-2
spellingShingle Rachel E. Christensen, BS
Mohammad Jafferany, MD
Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary
JAAD International
AA
alopecia areata
COVID-19
inflammation
SARS-CoV-2
title Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary
title_full Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary
title_fullStr Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary
title_full_unstemmed Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary
title_short Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary
title_sort association between alopecia areata and covid 19 a systematic reviewcapsule summary
topic AA
alopecia areata
COVID-19
inflammation
SARS-CoV-2
url http://www.sciencedirect.com/science/article/pii/S2666328722000177
work_keys_str_mv AT rachelechristensenbs associationbetweenalopeciaareataandcovid19asystematicreviewcapsulesummary
AT mohammadjafferanymd associationbetweenalopeciaareataandcovid19asystematicreviewcapsulesummary